JAMA does not have a built-in citation generator (the "Cite This" link does not conform with any citation styles used at Santa Fe College). You may use the following template for citing articles found using this database.
Author(s). (Date). Title of article. Journal of the American Medical Association, Volume(Issue), pages–pages. DOI
Author(s). "Title of Article." Journal of the American Medical Association, vol. X, no. X, Date, pp. X-X. DOI.
Author(s). Year. "Title of Article." Journal of the American Medical Association Volume (Issue): Page range. DOI.
Author(s). "Title of Article." Journal of the American Medical Association Volume, no. Issue (Date): Page range. DOI.
Goodwin, P. J., Chen, B. E., Gelmon, K. A., Whelan, T. J., Ennis, M., Lemieux, J., Ligibel, J. A., Hershman, D. L., Mayer, I. A., Hobday, T. J., Bliss, J. M., Rastogi, P., Rabaglio-Poretti, M., Mukherjee, S. D., Mackey, J. R., Abramson, V. G., Oja, C., Wesolowski, R., Thompson, A. M. ... Parulekar, W. R. (2022). Effect of metformin vs placebo on invasive disease-free survival in patients with breast cancer: The MA.32 randomized clinical trial. Journal of the American Medical Association, 327(20), 1963–1973. https://doi.org/10.1001/jama.2022.6147
U.S. Preventive Services Task Force. (2022). Aspirin use to prevent cardiovascular disease: US Preventive Services Task Force recommendation statement. Journal of the American Medical Association, 327(16), 1577–1584. https://doi.org/10.1001/jama.2022.4983
More Information: APA: Journal Articles
Goodwin, Pamela J., et al. "Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial." Journal of the American Medical Association, vol. 327, no. 20, 2022, pp. 1963-1973. https://doi.org/10.100710.1001/jama.2022.6147.
U.S. Preventive Services Task Force. "Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement." Journal of the American Medical Association, vol. 327, no. 16, 2022, pp. 1577-1584. https://doi.org/10.1001/jama.2022.4983.
More Information: MLA: Journal Articles
Goodwin, Pamela J., Bingshu E. Chen, Karen A. Gelmon, Timothy J. Whelan, Marguerite Ennis, Julie Lemieux, Jennifer A. Ligibel, et al. 2022. "Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial." Journal of the American Medical Association 327 (20): 1963–1973. https://doi.org/10.1001/jama.2022.6147
U.S. Preventive Services Task Force. 2022. "Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement." Journal of the American Medical Association 327 (16): 1577–1584. https://doi.org/10.1001/jama.2022.4983.
More Information: Chicago Author-Date: Journal Articles
Goodwin, Pamela J., Bingshu E. Chen, Karen A. Gelmon, Timothy J. Whelan, Marguerite Ennis, Julie Lemieux, Jennifer A. Ligibel, et al. "Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial." Journal of the American Medical Association 327, no. 20 (2022): 1963–1973. https://doi.org/10.1001/jama.2022.6147.
US Preventive Services Task Force. "Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement." Journal of the American Medical Association 327, no. 16 (2022): 1577–1584. https://doi.org/10.1001/jama.2022.4983.
Pamela J. Goodwin, Bingshu E. Chen, Karen A. Gelmon, Timothy J. Whelan, Marguerite Ennis, Julie Lemieux, Jennifer A. Ligibel, et al., "Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial," Journal of the American Medical Association 327, no. 20 (2022): 1972*, https://doi.org/10.1001/jama.2022.6147.
US Preventive Services Task Force, "Aspirin Use to Prevent Cardiovascular Disease: US Preventive Services Task Force Recommendation Statement," Journal of the American Medical Association 327, no. 16 (2022): 1579*, https://doi.org/10.1001/jama.2022.4983.
*Only include the pages that are directly being referenced, not the entire page range.
More Information: Chicago Notes & Bibliography: Journal Articles
Commitment to Equal Access and Equal Opportunity
Santa Fe College is committed to an environment that embraces diversity, respects the rights of all individuals, is open and accessible, and is free of harassment and discrimination. For more information, visit sfcollege.edu/eaeo or contact equity.officer@sfcollege.edu.
SACSCOC Accreditation Statement
Santa Fe College is accredited by the Southern Association of Colleges and Schools Commission on Colleges (SACSCOC). For more information, visit sfcollege.edu/sacscoc.